Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation

Prostate

Volumn 40, Issue 1, 1999, Pages 50-55

  Wang, Jing Ding ^a   Takahara, Shiro ^a   Nonomura, Norio ^a   Ichimaru, Naotsugu ^a   Toki, Kiyohide ^a   Azuma, Haruhito ^b   Matsumiya, Kiyomi ^a   Okuyama, Akihiko ^a   Suzuki, Seiichi ^c  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Androgen independent prostate cancer; Apoptosis; Caspases; DU145 cell line; FTY720

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; DNA FRAGMENT; FAS ANTIGEN;

ANDROGEN BLOOD LEVEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL LINE; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE INDUCTION; GENE ISOLATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

ANDROGENS; APOPTOSIS; CASPASE 3; CASPASES; HUMANS; MALE; PROPYLENE GLYCOLS; PROSTATIC NEOPLASMS; SPHINGOSINE; TUMOR CELLS, CULTURED;

EID: 0033564177     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990615)40:1<50::AID-PROS6>3.0.CO;2-N     Document Type: Article

References (20)

1. Boring CC, Squires TS, Tong T. Cancer statistics. CA Cancer J Clin 1993;43:7-26.
2. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy. J Urol 1994;152:1831-1836.
3. Stamey TA, McNeal JE. Campbell's urology, 6th ed. Philadelphia: W.B. Saunders; 1992.
4. Kozlowski JM, Ellis WJ, Grayhack JT. Advanced prostatic carcinoma. Early versus late endocrine therapy. Urol Clin North Am 1991;18:15-24.
5. Isaacs JT, Lundmo PI, Berges R, Martikainen P, Kyprianou N, English HF. Androgen regulation of programmed death of normal and malignant prostatic cells. J Androl 1992;13:457-464.
6. Ismail M, Gomella LG. Current treatment of advanced prostate cancer. Tech Urol 1997;3:16-24.
7. Adachi K, Kohara T, Naao N, Arita M, Chiba K, Mishina T, Sasaki S, Fujita T. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propnediols: discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem Lett 1995;5:853-856.
8. Enosawa S, Suzuki S, Kakefuda T, Li XK, Amemiya H. Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. Immunopharmacology 1996;34:171-179.
9. Suzuki S, Li XK, Shinomiya T, Enosawa S, Amemiya H, Amari M, Naoe S. The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720. Clin Exp Immunol 1997; 107:103-111.
10. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997;57:1758-1768.
11. Rokhlin OW, Hostager BS, Bishop GA, Sidorenko SP, Glover RA, Gudkov AV, Cohen MB. Dominant nature of the resistance to Fas-and tumor necrosis factor-a-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997;57:3941-3943.
12. Nicholson D, Ali A, Thornberry N, Vaillancourt J, Ding C, Gallant M, Gareau Y, Griffin P, Labelle M, Lazebnik Y, Munday N, Raju S, Smulson M, Yamin T-T, Yu V, Miler D. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
13. Raghavan D. Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs. Semin Qncol 1988;15:371-389.
14. Suzuki S, Enosawa S, Kakefuda T, Shinomiya T, Amari M, Naoe S, Hoshino Y, Chiba K. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996;61:200-205.
15. Stone KR, Michey DD, Wunderli H, Michey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 1978;21:274-281.
16. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171-178.
17. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16.
18. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992;52: 6940-6944.
19. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 1996;27:4573-4576.
20. Suzuki S, Li XK, Enosawa S, Shinomiya T. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 1996;89:518-523.